Smolinski column
Morning Consult article (link)
CMS Proposes 2.3% Pay Hike For Inpatient Rehab Facilities In Fiscal 2020
Smolinski quoted
Inside Washington Publishers article (subscription required)
Smolinski on CNBC: Expect a fiery hearing on Capitol Hill today over the role of pharmacy middle men in drug pricing
Smolinski interviewed
CNBC video (link)
U.S. government boosts 2020 Medicare payments to insurers by 2.53 percent
Smolinski quoted
Reuters article
GOP Feud Brews as Trump Sidesteps Congress on Health Payments
Smolinski quoted
Bloomberg Law article
Capitol Street proudly sponsors the DC Brewer's Ball, 10th annual. Benefits to Cystic Fibrosis Foundation
Sen. Grassley says probe of 'secretive' drug industry pricing won't stop with drugmakers
Smolinski quoted
CNBC.com article
Social Determinants May Be an Easier Nut to Crack
Smolinski column
Morning Consult article (link)
Smolinski on CNBC: Why drug prices are so high, and how the bluebird bio 5 year payment plan for its brand new gene therapy may pan out
Smolinski interviewed
CNBC NBR video (link)
JP Morgan Healthcare Conference: Smolinski moderates Liquid Biopsy cancer panel
Capitol Street’s Ipsita Smolinski moderated a Liquid Biopsy cancer panel at the 37th Annual JPMorgan Healthcare Conference in San Francisco with JPM's Tycho Peterson. The esteemed panel consisted of: Guardant CEO Helmy Eltoukhy, Palmetto Medical Director Paul Gerrard, LabCorps Medical Director James Almas, and Third Rock Ventures Partner Steve Kafka, formerly of Foundation Medicine.
JP Morgan Healthcare Conference (website link)
Smolinski on CNBC: Outlook for Health Stocks After Texas Judge Issues Ruling Against the ACA
Smolinski interviewed
CNBC video (link)
Updating the Area Wage Index: We Could Fix It Or Just Move to Value-Based Payments
Smolinski column
Morning Consult article (link)
Smolinski provides post election Medicaid program and prescription drug policy outlook for BioCentury
Smolinski quoted
BioCentury article (subscription required)
Ipsita Smolinski of Capitol Street and Jared Holz of Jefferies join 'Closing Bell' to discuss the health care sector and how drug pricing could be changed following the midterm elections.
Smolinski interviewed
CNBC video (link)
Smolinski addresses Association for Value Based Cancer Care summit in NYC
Smolinski on CNBC: How the Trump administration's new drug pricing proposal can impact pharma stocks
Smolinski interviewed
CNBC video (link)
Smolinski providers policy perspectives at Barclay’s Payors & Providers Conference in NYC
Smolinski provides Washington policy perspectives at annual AdvaMed Convention in Philadelphia, PA
Panel included:
Steve Beuchaw, Executive Director, Morgan Stanley
Donna Hochberg, Partner, Health Advances, LLC
Eric Lev, Partner, Ampersand Capital Partner
Brian Miller, Managing Partner, Linden Capital Partners; Board Member, AdvaMedDx
Ipsita Smolinski, Managing Director, Capitol Street and Senior Strategic Advisor, McCallister & Quinn
Vertical Health Care Mergers: Innovation or Just Less Competition?
Smolinski column
Morning Consult article (link)
U.S. to consider expanding Medicare drug price negotiation
Smolinski quoted
Reuters article (link)